| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 36.27B | 32.70B | 28.91B | 32.24B | 35.03B |
| Gross Profit | 11.55B | 9.67B | 7.94B | 10.27B | 10.23B |
| EBITDA | 9.21B | 7.91B | 6.03B | 8.24B | 8.30B |
| Net Income | 6.89B | 4.04B | 3.27B | 4.73B | 5.00B |
Balance Sheet | |||||
| Total Assets | 63.71B | 59.96B | 54.64B | 52.84B | 49.87B |
| Cash, Cash Equivalents and Short-Term Investments | 15.92B | 13.05B | 7.89B | 8.09B | 9.92B |
| Total Debt | 1.40B | 3.53B | 4.94B | 3.60B | 2.29B |
| Total Liabilities | 13.18B | 13.82B | 11.01B | 11.44B | 10.74B |
| Stockholders Equity | 49.70B | 45.44B | 42.98B | 40.83B | 38.65B |
Cash Flow | |||||
| Free Cash Flow | 5.87B | 7.57B | -337.47M | -773.50M | 3.52B |
| Operating Cash Flow | 7.09B | 8.60B | 4.37B | 4.73B | 5.84B |
| Investing Cash Flow | 1.46B | -298.37M | -4.13B | -4.85B | -1.04B |
| Financing Cash Flow | -5.88B | -3.13B | -476.17M | -1.56B | -1.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥113.83B | 7.40 | 9.19% | 3.33% | -10.12% | 276.36% | |
77 Outperform | ¥125.61B | 16.30 | 15.07% | 1.74% | 7.82% | 64.90% | |
76 Outperform | ¥91.66B | 28.34 | 6.31% | 4.01% | 1.41% | 7.59% | |
73 Outperform | ¥76.30B | 8.92 | ― | 3.04% | -0.37% | -20.95% | |
70 Outperform | ¥85.08B | 11.29 | ― | 3.74% | 0.53% | 30.98% | |
69 Neutral | ¥54.49B | 12.13 | ― | 2.92% | -5.24% | 17.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |